Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women

American Journal of Clinical Nutrition

Volumn 60, Issue 3, 1994, Pages 333-340

  Cassidy, Aedin ^b   Bingham, Sheila ^c   Setchell, Kenneth D R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CHOLESTEROL; DAIDZEIN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GENISTEIN; ISOFLAVONE; LUTEINIZING HORMONE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; SOYBEAN PROTEIN; TAMOXIFEN; TESTOSTERONE;

ADULT; ARTICLE; BODY WEIGHT; BREAST CANCER; CALORIC INTAKE; CHINA; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; JAPAN; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; NORMAL HUMAN; PREMENOPAUSE; PROTEIN DIET; RISK FACTOR;

GLYCINE MAX;

EID: 0028136777     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/60.3.333     Document Type: Article

References (52)

1. Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer incidence in five continents. Vol 5. Lyon, France: International Agency for Research on Cancer, 1987. (IARC Scientific publication no 88.)
2. Committee on Diet, Nutrition, and Cancer, Assembly of Life Sciences, National Research Council. Diet, nutrition, and cancer. Washington. DC: National Academy Press, 1982.
3. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Dietary fat and the risk of breast cancer. N Engl J Med 1987;316:22-8.
4. Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-43.
5. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality rates in different countries with special reference to dietary practices. Int J Cancer 1975;15:617-31.
6. Setchell KDR, Welsh M, Lim CK. High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection. J Chromatogr 1987;386:315-23.
7. Setchell KDR, Adlercreutz H. Mammalian lignans and phytoestrogens: recent studies on their formation, metabolism and biological role in health and disease. In: Rowland IA, ed. The role of gut microflora in toxicity and cancer. New York: Academic Press, 1988:315-45.
8. Setchell KDR, Borriello SP, Hulme P, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984;40:569-78.
9. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumor growth in models of breast cancer. In: Pariza MW, ed. Mutagens and carcinogens in the diet. New York: Wiley-Liss, 1990:239-53.
10. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia Aust Vet J 1946;22:2-12.
11. Shutt DA. The effect of plant oestrogens on animal reproduction. Endeavour 1976;35:110-3.
12. Setchell KDR, Gosselin SJ, Welsh M, et al. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetah. Gastroenterology 1987;93:225-33.
13. Schofield NW, Schofield C, James WPT. Basal metabolic rate. Hum Nutr Clin Nutr 1985;39C(suppl 1):1-96.
14. Bingham S, Cummings JH. The use of 4-amino benzoic acid as a marker to validate the completeness of 24 hour urine collections in man. Clin Sci 1983;64:629-35.
15. Cummings JH, Jenkins DJA, Wiggins HS. Measurement of the mean transit time of dietary residue through the human gut. Gut 1976; 17:210-8.
16. Barbuch RJ, Coutant JE, Setchell KDR, Welsh MB. The use of thermospray LC/MS/MS for the class identification and structural verification of phytoestrogens in soy protein preparations. J Biomed Mass Spectrom 1989;18:973-7.
17. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KDR. The identification of the weak estrogen equol in human urine. Biochem J 1982;201:353-7.
18. McLachlan J, ed. Estrogens in the environment: influence on development. New York: Elsevier, 1985.
19. Price KR, Fenwick GR. Naturally occurring oestrogens in foods - a review. Food Addit Contam 1985;2:73-106.
20. Setchell KDR. Naturally occurring non-steroidal estrogens of dietary origin. In: McLachlan J, ed. Estrogens in the environment: influence on development. New York: Elsevier, 1985:69-85.
21. Setchell KDR, Lawson AM, Borriello SP, et al. Lignan formation in man - microbial involvement and possible roles in relation to cancer. Lancet 1981;2:4-8.
22. Adlercreutz H. Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of "fiber hypothesis". Gastroenterology 1984;86:761-6.
23. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 1990;201:3-21.
24. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet 1991;337:1197-200.
25. Henderson BE, Ross RK, Judd HL, Frailo MD, Pike MC. Do regulatory ovulatory cycles increase breast cancer risk? Cancer 1985; 56:1206-8.
26. Olsson H, Landin-Olsson M, Gullberg B. Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease. J Natl Cancer Inst 1983;70:17-20.
27. Treolar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1970;12:77-126.
28. World Health Organization. A prospective multicenter trial of the ovulation method of natural family planning. III Characteristics of the menstrual cycle and of the fertile phase. Fertil Steril 1983;40: 773-8.
29. Munster K, Schmidt L, Helm P. Length and variation in the menstrual cycle - a cross sectional study from a Danish county. Br J Obstet Gynaecol 1992;99:422-9.
30. Coward L, Barnes NC, Setchell KDR, Barnes S. The isoflavones genistein and daidzein in soy bean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
31. Adlercreutz H, Honjo A, Higashi A, et al. Lignan and phytoestrogen excretion in Japanese consuming traditional diet. Scand J Clin Invest, 1988;48:190 (abstr).
32. Cassidy A, Bingham S, Carlson J, Setchell KDR. Biological effects of plant estrogens in premenopausal women. FASEB J 1993;A866 (abstr).
33. Aksel S. Hormonal characteristics of long cycles in fertile women. Fertil Steril 1981;36:521-3.
34. Ferguson DJP, Anderson TJ. Morphological evaluation of cell turn-over in relation to the menstrual cycle in the "resting" human breast. Br J Cancer 1981;44:177-81.
35. Key TJA, Chen DY, Wang DY, Pike MC, Boreham J. Sex hormones in rural China and Britain. Br J Cancer 1990;62:631-6.
36. Miller WR. Endocrine treatment for breast cancer. Biological rationale and current progress. J Steroid Biochem 1990;37:467-80.
37. Willis KJ, London DR, Ward HWC, Butt WR, Lynch SS, Rudd BT. Recurrent breast cancer treated with the antiestrogen tamoxifen: correlation between hormonal changes and clinical course. Br Med J 1977;1:425-8.
38. Jordan VC, Fritz NF, Tormey DC. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration of node-positive patients with breast cancer. Cancer Res 1987;47:624-30.
39. Golder MP, Phillips EA, Fahmy DR, et al. Plasma hormones in patients with advanced breast cancer treated with tamoxifen. Eur J Cancer, 1976;12:719-23.
40. Jordan VC, Fritz NF, Tormey DC. Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III. Cancer Res 1987;47:4517-9.
41. Love RR, Newcomb PA, Wiebe DA, et al. Effects of tamoxifen on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst 1990;82:1327-32.
42. Baglade JD, Wolter J, Subbaiah PV, Ryan W. Effects of tamoxifen on plasma lipids and lipoprotein lipid composition. J Clin Endocrinol Metab 1990;70:1132-5.
43. Sakai F, Cheix F, Clavel M, et al. Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. J Endocrinol 1978;76:219-26.
44. Vincze B, Szamel I, Hindy I, Kerpel-Fronius S, Eckhardt S. Determination of free estradiol concentration and the binding capacity of SHBG in the serum of patients treated with tamoxifen. In: Gorog, ed. Advances in steroid analysis. Budapest: Akademia Kiado, 1982:107-12.
45. Szamel I, Vincze B, Hindy I, Hermann I, Borvendeg J, Eckhardt S. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer. Oncology 1986;43:7-11.
46. Bruning PF, Bonfrer JMG, Hart AAM, et al. Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer, 1988;58:497-9.
47. Carroll KK, Giovannetti PM, Huff MW, Moase O, Roberts DCK, Wolfe BM. Hypocholesterolemic effect of substituting soybean protein for animal protein in the diet of healthy young women. Am J Clin Nutr 1978;31:1312-21.
48. Sirtori CR, Gatti E, Mantero O, et al. Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia. Am J Clin Nutr. 1979;32:1645-58.
49. Cruz MLA, Wong WW, Mimouni F, et al. Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994;35:135-46.
50. Powles TJ, Hardy JR, Ashley SE, et al. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for the prevention of breast cancer. Br J Cancer 1989;60:126-31.
51. Powles TJ, Tillyer CR, Jones AL, et al. Prevention of breast cancer with tamoxifen - an update on the Royal Marsden Hospital Pilot Programme. Eur J Cancer 1990;26:680-4.
52. Davidson NE. Tamoxifen - panacea or Pandora's box. N Engl J Med 1992;326:885-6.